News
-
-
PRESS RELEASE
Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial
Nicox announces the publication of the adaptive design period of the NCX 470 Mont Blanc Phase 3 trial, selecting 0.1% concentration due to better intraocular pressure reduction and safety profile -
PRESS RELEASE
Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470
Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470, dévoilant une réduction significative de la pression intraoculaire avec une concentration de 0,1 %, confirmant son choix pour les études en cours -
-
-
-
-
PRESS RELEASE
Sonova first half year results 2024/25: Solid sales growth in the first half, acceleration through successful platform launches expected
Sonova Holding AG reports solid sales growth in the first half of 2024/25, driven by successful platform launches, with expectations of accelerated growth. Adjusted EBITA impacted by launch-related costs and lead-generation costs -
-
PRESS RELEASE
Springer Nature delivered continued growth in the first nine months of 2024 and confirms full-year guidance
Springer Nature reports continued growth in the first nine months of 2024, driven by Research segment and technology solutions. Confirms full-year guidance. CEO emphasizes commitment to goals and communities
